Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden
· Delayed Price · Currency is SEK 9.78
-0.13 (-1.31%)
Mar 6, 2026, 5:29 PM CET
Vicore Pharma Holding AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3.82 | 109.35 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | -96.51% | - | - | - | - | Upgrade
|
| Gross Profit | 3.82 | 109.35 | - | - | - | Upgrade
|
| Selling, General & Admin | 67.91 | 50.44 | 44.6 | 37.53 | 21.61 | Upgrade
|
| Research & Development | 390.35 | 249.26 | 276.29 | 249.97 | 271.81 | Upgrade
|
| Operating Expenses | 458.26 | 299.71 | 320.89 | 287.49 | 293.42 | Upgrade
|
| Operating Income | -454.45 | -190.36 | -320.89 | -287.49 | -293.42 | Upgrade
|
| Interest Expense | -50.35 | -0.01 | -0 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 25.26 | 21.08 | 10.54 | 0.91 | 0.65 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.06 | 0.4 | -0.62 | -1.75 | -1.83 | Upgrade
|
| EBT Excluding Unusual Items | -477.47 | -168.89 | -310.97 | -288.34 | -294.61 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.36 | -0.47 | -2.12 | Upgrade
|
| Pretax Income | -477.47 | -168.89 | -311.33 | -288.81 | -296.74 | Upgrade
|
| Income Tax Expense | - | -0.26 | -0.38 | -0.38 | -0.25 | Upgrade
|
| Net Income | -477.47 | -168.63 | -310.94 | -288.42 | -296.48 | Upgrade
|
| Net Income to Common | -477.47 | -168.63 | -310.94 | -288.42 | -296.48 | Upgrade
|
| Shares Outstanding (Basic) | 240 | 137 | 97 | 72 | 70 | Upgrade
|
| Shares Outstanding (Diluted) | 240 | 137 | 97 | 72 | 70 | Upgrade
|
| Shares Change (YoY) | 75.30% | 41.72% | 33.71% | 3.64% | 28.44% | Upgrade
|
| EPS (Basic) | -1.99 | -1.23 | -3.22 | -3.99 | -4.25 | Upgrade
|
| EPS (Diluted) | -1.99 | -1.23 | -3.22 | -3.99 | -4.25 | Upgrade
|
| Free Cash Flow | -374.44 | -164.95 | -249.58 | -299.92 | -265.17 | Upgrade
|
| Free Cash Flow Per Share | -1.56 | -1.21 | -2.58 | -4.15 | -3.81 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | - | - | Upgrade
|
| Operating Margin | -11905.82% | -174.09% | - | - | - | Upgrade
|
| Profit Margin | -12509.14% | -154.22% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -9809.67% | -150.85% | - | - | - | Upgrade
|
| EBITDA | -452.2 | -188.12 | -317.47 | -283.88 | -290.06 | Upgrade
|
| EBITDA Margin | - | -172.04% | - | - | - | Upgrade
|
| D&A For EBITDA | 2.24 | 2.24 | 3.42 | 3.61 | 3.36 | Upgrade
|
| EBIT | -454.45 | -190.36 | -320.89 | -287.49 | -293.42 | Upgrade
|
| EBIT Margin | - | -174.09% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.